P/E Ratio (TTM)
-17.18
Centessa Pharmaceuticals plc currently has a P/E ratio of -17.18. The P/E ratio is a primary valuation multiple used to determine if a stock is overvalued or undervalued relative to its earnings.
Quarterly P/E
| Quarter | P/E Ratio |
|---|---|
| 2020-03-31 | -192.28 |
| 2020-06-30 | -259.85 |
| 2020-09-30 | -270.79 |
| 2020-12-31 | -176.19 |
| 2021-03-31 | -1.98 |
| 2021-06-30 | -8.51 |
| 2021-09-30 | -9.35 |
| 2021-12-31 | — |
| 2022-03-31 | -3.72 |
| 2022-06-30 | -1.77 |
| 2022-09-30 | -1.76 |
| 2022-12-31 | -1.70 |
| 2023-03-31 | -1.80 |
| 2023-06-30 | -5.92 |
| 2023-09-30 | -4.04 |
| 2023-12-31 | -5.29 |
| 2024-03-31 | -7.27 |
| 2024-06-30 | -5.50 |
| 2024-09-30 | -10.92 |
| 2024-12-31 | -4.97 |
| 2025-03-31 | -18.30 |
| 2025-06-30 | -8.72 |
| 2025-09-30 | -14.82 |
Annual P/E
| Year | P/E Ratio |
|---|
* P/E ratios are calculated using trailing twelve-month (TTM) earnings. Extreme values may indicate earnings anomalies or cyclical volatility.